https://www.mangaloremirror.com/akro-investor-deadline-robbins-geller-rudman-dowd-llp-files-class-action-lawsuit-against-akero-therapeutics-inc-and-announces-opportunity-for-investors-with-substantial-losses-to-lead-case/
AKRO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case